The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 10,963,759 | 344,123 | SH | SOLE | 344,123 | 0 | 0 | |||
| ACELYRIN INC | COM | 00445A100 | 10,665,000 | 1,580,000 | SH | SOLE | 1,580,000 | 0 | 0 | |||
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 1,597,400 | 1,630,000 | SH | SOLE | 1,630,000 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 3,068,100 | 2,435,000 | SH | SOLE | 2,435,000 | 0 | 0 | |||
| APPLIED THERAPEUTICS | COM | 03828A101 | 3,659,875 | 1,770,000 | SH | SOLE | 1,770,000 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 13,622,400 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | |||
| BIODESIX | COM | 09075X108 | 764,560 | 534,657 | SH | SOLE | 534,657 | 0 | 0 | |||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 16,009,419 | 1,004,355 | SH | SOLE | 1,004,355 | 0 | 0 | |||
| CODEXIS INC | COM | 192005106 | 10,888,800 | 3,120,000 | SH | SOLE | 3,120,000 | 0 | 0 | |||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 6,276,600 | 3,170,000 | SH | SOLE | 3,170,000 | 0 | 0 | |||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 1,529,533 | 1,108,357 | SH | SOLE | 1,108,357 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 210,000 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | |||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 455,543 | 113,038 | SH | SOLE | 113,038 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 12,129,600 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | |||
| ETON PHARMACEUTICALS INC | COM | 29772L108 | 9,171,679 | 2,445,781 | SH | SOLE | 2,445,781 | 0 | 0 | |||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,227,200 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
| GLAUKOS CORP | COM | 377322102 | 808,631 | 8,576 | SH | SOLE | 8,576 | 0 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 2,879,329 | 2,440,109 | SH | SOLE | 2,440,109 | 0 | 0 | |||
| GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 3,212,928 | 8,000,000 | PRN | SOLE | 8,000,000 | 0 | 0 | |||
| HARROW HEALTH INC | COM | 415858109 | 51,869,538 | 3,920,600 | SH | SOLE | 3,920,600 | 0 | 0 | |||
| IBIO INC | COM NEW | 451033708 | 2,760,800 | 680,000 | SH | SOLE | 680,000 | 0 | 0 | |||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 7,015,050 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | |||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 13,293,540 | 897,000 | SH | SOLE | 897,000 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 12,788,423 | 435,573 | SH | SOLE | 435,573 | 0 | 0 | |||
| KEROS THERAPEUTICS INC | COM | 492327101 | 24,328,500 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | |||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,323,795 | 174,413 | SH | SOLE | 174,413 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 5,826,250 | 395,000 | SH | SOLE | 395,000 | 0 | 0 | |||
| LYELL IMMUNOPHARMA INC | COM | 55083R104 | 7,481,650 | 3,355,000 | SH | SOLE | 3,355,000 | 0 | 0 | |||
| MORPHOSYS AG | SPONSORED ADS | 617760202 | 1,179,100 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 7,458,926 | 315,388 | SH | SOLE | 315,388 | 0 | 0 | |||
| NYXOAH S A | SHS | B6S7WD106 | 4,316,800 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 60,543,556 | 6,653,138 | SH | SOLE | 6,653,138 | 0 | 0 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 802,130 | 471,481 | SH | SOLE | 471,481 | 0 | 0 | |||
| PRECIGEN INC | COM | 74017N105 | 1,373,875 | 947,500 | SH | SOLE | 947,500 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,260,411 | 112,700 | SH | SOLE | 112,700 | 0 | 0 | |||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 10,797,302 | 2,692,594 | SH | SOLE | 2,692,594 | 0 | 0 | |||
| REGULUS THERAPEUTICS INC | COM | 75915K309 | 490,487 | 170,308 | SH | SOLE | 170,308 | 0 | 0 | |||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 3,529,350 | 759,000 | SH | SOLE | 759,000 | 0 | 0 | |||
| REPARE THERAPEUTICS iNC | COM | 760273102 | 318,212 | 67,561 | SH | SOLE | 67,561 | 0 | 0 | |||
| REVANCE THERAPEUTICS INC | COM | 761330109 | 3,862,200 | 785,000 | SH | SOLE | 785,000 | 0 | 0 | |||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 22,314,950 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | |||
| SAVARA INC | COM | 805111101 | 4,257,900 | 855,000 | SH | SOLE | 855,000 | 0 | 0 | |||
| SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 4,212,831 | 787,545 | SH | SOLE | 787,545 | 0 | 0 | |||
| TG THERAPEUTICS INC | COM | 88322Q108 | 34,678,800 | 2,280,000 | SH | SOLE | 2,280,000 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 9,125,250 | 2,645,000 | SH | SOLE | 2,645,000 | 0 | 0 | |||
| UROGEN PHARMA LTD | COM | M96088105 | 4,050,000 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 5,806,350 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 7,067,500 | 1,285,000 | SH | SOLE | 1,285,000 | 0 | 0 | |||
| VERASTEM INC | COM NEW | 92337C203 | 2,494,520 | 211,400 | SH | SOLE | 211,400 | 0 | 0 | |||
| XOMA CORP DEL | COM NEW | 98419J206 | 6,012,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 3,152,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||